National Kidney Foundation K/DOQI Clinical Practice Guidelines for Bone

Total Page:16

File Type:pdf, Size:1020Kb

National Kidney Foundation K/DOQI Clinical Practice Guidelines for Bone The Official Journal of the National Kidney Foundation American Journal of Kidney Diseases AJKDEditorial correspondence and manuscript submis- The appearance of the code at the bottom of the first sions should be addressed to Bertram L. Kasiske, MD, page of an article in this journal indicates the copyright Editor-in-Chief, AJKD, Hennepin Faculty Associates, owner’s consent that copies of the article may be made for 600 HFA Building, Room D508, 914 South 8th Street, personal or internal use, or for the personal or in- Minneapolis, MN 55404. Telephone: (612) 347-7770 ternal use of specific clients. This consent is given on the Business correspondence (subscriptions, change condition, however, that the copier pay the stated per-copy of address) should be addressed to the Publisher, fee through the Copyright Clearance Center, Inc (222 W.B. Saunders, Periodicals Department, 6277 Sea Rosewood Dr, Danvers, MA 01923; (978) 750-8400) for Harbor Dr, Orlando, FL 32887-4800. E-mail: elspcs@ copying beyond that permitted by Sections 107 or 108 of elsevier.com the US Copyright Law. This consent does not extend to Change of address notices, including both the old and other kinds of copying, such as copying for general distri- new addresses of the subscriber, should be sent at least one bution, for advertising or promotional purposes, for creat- month in advance. ing new collective works, or for resale. Absence of the code Customer Service: 1-800-654-2452; outside the United indicates that the material may not be processed through States and Canada, 1-407-345-4000. the Copyright Clearance Center, Inc. Reprints of single Yearly subscription rates: United States and posses- articles available online may be obtained by purchasing sions: individual, $346.00; institution, $572.00; single Pay-Per-View access for $25 per article on the journal web issue, $52.00. All other countries: individual, $530.00; site, www.ajkd.org institution, $618.00; single issue, $52.00. For all areas Reprints: For 100 or more copies of an article in this outside the United States and possessions, there is no publication, please contact the Commercial Reprints De- additional charge for surface delivery. For air mail deliv- partment, Elsevier Science Inc., 360 Park Avenue South, ery, add $48.00. Student and resident: United States and New York, NY 10010-1710. Telephone: (212) 633-3813; possessions, $175.00; all other countries, $231.00. To Fax: (212) 633-3820; e-mail: [email protected] receive student/resident rate, orders must be accompa- Advertising representative: Cunningham Associates, nied by name of affiliated institution, date of term, and 180 Old Tappan Rd, Old Tappan, NJ 07675. Telephone the signature of program/residency coordinator on insti- 1-201-767-4170; fax 1-201-767-8065. tution letterhead. Orders will be billed at individual rate The ideas and opinions expressed in the American until proof of status is received. Single issues, both Journal of Kidney Diseases do not necessarily reflect current and back, exist in limited quantities and are offered for sale subject to availability. Current prices are those of the National Kidney Foundation, the Editor, or in effect for back volumes and back issues. Back issues the Publisher. Publication of an advertisement or other sold in conjunction with a subscription are on a pro- product mentioned in the American Journal of Kidney rated basis. 2002 bound volume price: $95.00; foreign Diseases should not be construed as an endorsement of customers, please add $15.00 for postage. To purchase a the product or the manufacturer’s claims. Readers are 2002 bound volume, customer must be a subscriber for encouraged to contact the manufacturer with any ques- 2002. Cumulative index (1983-1989) price: $95.00; for- tions about the features or limitations of the products eign customers, please add $2.25 for surface delivery, or mentioned. The National Kidney Foundation and the $8.00 for air mail delivery. Prices are subject to change Publisher do not assume any responsibility for any without notice. Checks should be made payable to W.B. injury and/or damage to persons or property arising out Saunders and sent to American Journal of Kidney Dis- of or related to any use of the material contained in this eases, W.B. Saunders, Periodicals Department, PO Box periodical. The reader is advised to check the appropri- 628239, Orlando, FL 32862-8239. ate medical literature and the product information cur- Copyright © 2003, National Kidney Foundation. All rently provided by the manufacturer of each drug to be rights reserved. No part of this publication may be repro- administered to verify the dosage, the method and dura- duced or transmitted in any form or by any means now tion of administration, or contraindications. It is the or hereafter known, electronic or mechanical, including responsibility of the treating physician or other health photocopy, recording, or any information storage and care professional, relying on independent experience retrieval system, without permission in writing from the and knowledge of the patient, to determine drug dos- publisher. Printed in the United States of America. ages and the best treatment for the patient. Permissions may be sought directly from Elsevier’s The contents of the American Journal of Kidney Dis- Rights Department in Philadelphia, PA, USA: phone 215- eases are indexed in Index Medicus and MEDLINE, Cur- 238-7869, fax 215-238-2239, e-mail healthpermissions@ rent Contents/Clinical Medicine, Science Citation In- elsevier.com. Requests may also be completed on-line dex, EMBASE/Excerpta Medica, ISI, and CINAHL. via the Elsevier homepage (www.elsevier.com/locate/ The American Journal of Kidney Diseases home page is permissions). located at www.ajkd.org. W.B. Saunders Philadelphia, PA The Official Journal of the National Kidney Foundation EDITORIAL BOARD American Journal of AJKD Kidney Diseases Editor-in-Chief Bertram L. Kasiske, MD Minneapolis, MN Co-Editors Blanche Chavers, MD Robert Foley, MB Minneapolis, MN Minneapolis, MN Mark Rosenberg, MD Suzanne Swan, MD Minneapolis, MN Minneapolis, MN Education Editor Pathology Editor Stuart Linas, MD Agnes Fogo, MD Denver, CO Nashville, TN Associate Editors George Bakris, MD Donald Hricik, MD Luis Ruilope, MD Chicago, IL Cleveland, OH Madrid, Spain Timothy Bunchman, MD Hi Bahl Lee, MD Nestor Schor, MD Grand Rapids, MI Seoul, Korea Sa˜o Paulo, Brazil Daniel Cattran, MD Adeera Levin, MD Catherine Stehman-Breen, MD Toronto, Canada Vancouver, Canada Seattle, WA Ricardo Correa-Rotter, MD Philip Kam Tao Li, MD Yasuhiko Tomino, MD Mexico City, Mexico Hong Kong, P.R.O.C. Tokyo, Japan Jonathan Craig, MBChB Francesco Locatelli, MD Katherine Tuttle, MD Sydney, Australia Lecco, Italy Spokane, WA Paul de Jong, MD Sharon Moe, MD Yves Vanrenterghem, MD Groningen, The Netherlands Indianapolis, IN Leuven, Belgium A. Meguid El Nahas, MD Emil Paganini, MD Christoph Wanner, MD Sheffield, United Kingdom Cleveland, OH Wu¨ rzburg, Germany Denis Fouque, MD Hamid Rabb, MD David Wheeler, MD Lyon, France Baltimore, MD London, United Kingdom Thomas Golper, MD Nashville, TN Statistical Reviewers David Gilbertson, PhD Jon Snyder, MS Minneapolis, MN Minneapolis, MN Editorial Office Managing Editor Assistant Managing Editor Deanna Gunderson Anna Gillette Minneapolis, MN Minneapolis, MN The Official Journal of the National Kidney Foundation VOL 42, NO 4, SUPPL 3, OCTOBER 2003 CONTENTS American Journal of AJKD Kidney Diseases K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease Tables............................................................................................................................... S1 Figures ............................................................................................................................. S2 Algorithms ....................................................................................................................... S3 Acronyms and Abbreviations........................................................................................ S4 Work Group Membership ............................................................................................... S5 Foreword.......................................................................................................................... S7 Introduction ..................................................................................................................... S10 Guideline Statements ..................................................................................................... S12 Background ..................................................................................................................... S29 Methods for Analysis of Literature................................................................................ S45 Clinical Practice Guidelines Guideline 1. Evaluation of Calcium and Phosphorus Metabolism ............................ S52 Guideline 2. Assessment of Bone Disease Associated With CKD............................... S57 Guideline 3. Evaluation of Serum Phosphorus Levels ............................................... S62 Guideline 4. Restriction of Dietary Phosphorus in Patients With CKD ..................... S63 Guideline 5. Use of Phosphate Binders in CKD ......................................................... S70 Guideline 6. Serum Calcium and Calcium-Phosphorus Product .............................. S77 Guideline 7. Prevention and Treatment of Vitamin D Insufficiency and Vitamin D Deficiency in CKD Patients
Recommended publications
  • Management of Acute Clonidine Poisoning in Adults: the Role of Resin Hemoperfusion
    Management of Acute Clonidine Poisoning in Adults: The Role of Resin Hemoperfusion Shanshan Fang Department of Nephrology, 307 Hospital Bo Han Department of Nephrology, 307 Hospital Xiaoling Liu Department of Nephrology, 307 Hospital Dan Mao Department of Nephrology, 307 Hospital Chengwen Sun Laboratory of Poisonous Substance Detection, 307 Hospital Zhi Chen Department of Nephrology, 307 Hospital Ruimiao Wang Department of Nephrology, 307 Hospital Xishan Xiong ( [email protected] ) Aliated Hengsheng Hospital of the Southern Medical University https://orcid.org/0000-0002-8557- 8025 Methodology Keywords: clonidine poisoning, adrenergic alpha-agonists, bradycardia, hemoperfusion, hypotension Posted Date: September 21st, 2020 DOI: https://doi.org/10.21203/rs.3.rs-76660/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/14 Abstract Clonidine poisoning in adults is rare. An observational retrospective study including 102 adults with clonidine poisoning was conducted. 57 patients with relatively mild conditions were placed in the local emergency departments (EDs) for clinical observation, while the remaining 45 were transferred to the tertiary hospital for intensive treatment, of whom 9 were given supportive care only and 36 were given hemoperfusion (HP), as well as similar supportive treatment. The main symptoms of these cases were: sleepiness, dizziness, fatigue, headache, inarticulacy, tinnitus and dry mouth. Physical examination showed hypotension, bradycardia and shallow and slow breathing. Serum and urine clonidine concentrations were signicantly elevated24.4 ng/ml, 313.2 ng/ml, respectively. All cases slowly returned to their baseline state over 48 to 96 hours, which is co-related with the drawn of serum clonidine level.
    [Show full text]
  • Things You Might Like to Know About Duplicate Bridge
    ♠♥♦♣ THINGS YOU MIGHT LIKE TO KNOW ABOUT DUPLICATE BRIDGE Prepared by MayHem Published by the UNIT 241 Board of Directors ♠♥♦♣ Welcome to Duplicate Bridge and the ACBL This booklet has been designed to serve as a reference tool for miscellaneous information about duplicate bridge and its governing organization, the ACBL. It is intended for the newer or less than seasoned duplicate bridge players. Most of these things that follow, while not perfectly obvious to new players, are old hat to experienced tournaments players. Table of Contents Part 1. Expected In-behavior (or things you need to know).........................3 Part 2. Alerts and Announcements (learn to live with them....we have!)................................................4 Part 3. Types of Regular Events a. Stratified Games (Pairs and Teams)..............................................12 b. IMP Pairs (Pairs)...........................................................................13 c. Bracketed KO’s (Teams)...............................................................15 d. Swiss Teams and BAM Teams (Teams).......................................16 e. Continuous Pairs (Side Games)......................................................17 f. Strategy: IMPs vs Matchpoints......................................................18 Part 4. Special ACBL-Wide Events (they cost more!)................................20 Part 5. Glossary of Terms (from the ACBL website)..................................25 Part 6. FAQ (with answers hopefully).........................................................40 Copyright © 2004 MayHem 2 Part 1. Expected In-Behavior Just as all kinds of competitive-type endeavors have their expected in- behavior, so does duplicate bridge. One important thing to keep in mind is that this is a competitive adventure.....as opposed to the social outing that you may be used to at your rubber bridge games. Now that is not to say that you can=t be sociable at the duplicate table. Of course you can.....and should.....just don=t carry it to extreme by talking during the auction or play.
    [Show full text]
  • Bernard Magee's Acol Bidding Quiz
    Number: 178 UK £3.95 Europe €5.00 October 2017 Bernard Magee’s Acol Bidding Quiz This month we are dealing with hands when, if you choose to pass, the auction will end. You are West in BRIDGEthe auctions below, playing ‘Standard Acol’ with a weak no-trump (12-14 points) and four-card majors. 1. Dealer North. Love All. 4. Dealer West. Love All. 7. Dealer North. Love All. 10. Dealer East. E/W Game. ♠ 2 ♠ A K 3 ♠ A J 10 6 5 ♠ 4 2 ♥ A K 8 7 N ♥ A 8 7 6 N ♥ 10 9 8 4 3 N ♥ K Q 3 N W E W E W E W E ♦ J 9 8 6 5 ♦ A J 2 ♦ Void ♦ 7 6 5 S S S S ♣ Q J 3 ♣ Q J 6 ♣ A 7 4 ♣ K Q J 6 5 West North East South West North East South West North East South West North East South Pass Pass Pass 1♥ 1♠ Pass Pass 1♣ 2♦1 Pass 1♥ 1♠ ? ? Pass Dbl Pass Pass 2♣ 2♠ 3♥ 3♠ ? 4♥ 4♠ Pass Pass 1Weak jump overcall ? 2. Dealer North. Love All. 5. Dealer West. Love All. 8. Dealer East. Love All. 11. Dealer North. N/S Game. ♠ 2 ♠ A K 7 6 5 ♠ A 7 6 5 4 3 ♠ 4 3 2 ♥ A J N ♥ 4 N ♥ A K 3 N ♥ A 7 6 N W E W E W E W E ♦ 8 7 2 ♦ A K 3 ♦ 2 ♦ A 8 7 6 4 S S S S ♣ K Q J 10 5 4 3 ♣ J 10 8 2 ♣ A 5 2 ♣ 7 6 West North East South West North East South West North East South West North East South Pass Pass Pass 1♠ 2♥ Pass Pass 3♦ Pass 1♣ 3♥ Dbl ? ? Pass 3♥ Pass Pass 4♥ 4♠ Pass Pass ? ? 3.
    [Show full text]
  • Targeted High Volume Hemofiltration Could Avoid Extracorporeal Membrane Oxygenation in Some Patients with Severe Hantavirus Cardiopulmonary Syndrome
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 5 July 2020 doi:10.20944/preprints202007.0046.v1 Article Targeted High Volume Hemofiltration Could Avoid Extracorporeal Membrane Oxygenation in Some Patients with Severe Hantavirus Cardiopulmonary Syndrome René López1, 2, Rodrigo Pérez-Araos1, 3, Álvaro Salazar1, Mauricio Espinoza1, 2, Cecilia Vial4, Analia Cuiza 4, Pablo A. Vial2, 4, 5, and Jerónimo Graf1, 2* 1. Departamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago 7650567, Chile; [email protected] (R.L.); [email protected] (R.P-A.); [email protected] (Á .S.); [email protected] (M.E); [email protected] (J.G.) 2. Escuela de Medicina. Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago 7710162, Chile; [email protected] (P.A.V.) 3. Escuela de Kinesiología. Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago 7710162, Chile 4. Programa Hantavirus, Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago 7590943, Chile; [email protected] (C.V.); [email protected] (A.C.) 5. Departamento de Pediatría, Clínica Alemana de Santiago, Santiago 7650567, Chile Correspondence: [email protected] Abstract Background: Hantavirus cardiopulmonary syndrome (HCPS) has a high lethality. About two-thirds of the severe cases may be rescued by extracorporeal membrane oxygenation (ECMO). However, about half of the patients supported by ECMO suffer major complications. High volume hemofiltration (HVHF) is a depurative extracorporeal support that provides homeostatic balance allowing hemodynamic stabilization in some critically ill patients. Methods: We implemented HVHF prior to ECMO consideration in the last five severe HCPS patients requiring mechanical ventilation and vasoactive drugs admitted to our intensive care unit.
    [Show full text]
  • Im Zweiten Weltkrieg
    3 Von der Kaiserzeit bis zum Ende des Zweiten Weltkrieges 3 Bis zur Weimarer Republik 1870/71–1919 Urkunde vom Ende des Militärdienstes, Pfeife von 1875 für 15.07.1860 (Harm Kuiper) Harm Kuite, geb. den 6. April 1855. Inschrift: Der letzte Veteran von 1870/71 „Zum Andenken an meine Dienstzeit! Harm Keute Zeitung vom 18.05.1933 (1. Bl. Nr. 114) geb. den 6. April 1855 zu Berge Hoogstede, 18. Mai: Veteran Reinders †. Eingestellt den 3. Novbr.1875 bei der 12. Komp. D.K. Regt Nr. 78 in Aurich Der letzte Alt-Veteran des Kirchspiels Arkel, Zum Andenken von seinem Bruder der Landwirt Reinders aus Berge, wurde am Hermmans Keute. Für das kurze Menschenleben, die Freundschaft Montag zur letzten Ruhe gebracht. Reinders viel zu schön. Ewigkeiten muss es geben, nahm als Unteroffizier an dem Feldzug wo sich Freunde wiedersehn.’ (Harm Kuiper) 1870/71 teil. Bis ins in sein hohes Alter hin- Solche Pfeifen oder auch Tassen und Teller mit ein war er rüstig, noch am Tage vor seinem dem Namen des Beschenkten gab es vor 1900 viele. Es handelte sich um Einzelstücke, die Ableben fertigte er zwei Paar Holzschuhe an. persönlich beschriftet wurden. Es gab sie zur In voller Gesundheit erreichte er ein Alter von Entlassung aus dem Militärdienst oder auch als Geschenk unter Freunden. (gjb) 87 Jahren. 170 BIS ZUR WEIMARER REPUBLIK 1870/71 - 1919 Kaiser Wilhelm II. und Kaiserin Auguste Viktoria auf zwei Dosen, sogenannte Kaiserdosen, etwa 50 cm hoch. (Harm Kuiper) Heimkehr aus der Gefangenschaft gekochtes Sauerkraut und das auch noch in 19.03.1918 ungenügenden Mengen.
    [Show full text]
  • Tokyo 2020 Paralympic Games
    TOKYO 2020 PARALYMPIC GAMES QUALIFICATION REGULATIONS REVISED EDITION, APRIL 2021 INTERNATIONAL PARALYMPIC COMMITTEE 2 CONTENTS 1. Introduction 2. Tokyo 2020 Paralympic Games Programme Overview 3. General IPC Regulations on Eligibility 4. IPC Redistribution Policy of Vacant Qualification Slots 5. Universality Wild Cards 6. Key Dates 7. Archery 8. Athletics 9. Badminton 10. Boccia 11. Canoe 12. Cycling (Track and Road) 13. Equestrian 14. Football 5-a-side 15. Goalball 16. Judo 17. Powerlifting 18. Rowing 19. Shooting 20. Swimming 21. Table Tennis 22. Taekwondo 23. Triathlon 24. Volleyball (Sitting) 25. Wheelchair Basketball 26. Wheelchair Fencing 27. Wheelchair Rugby 28. Wheelchair Tennis 29. Glossary 30. Register of Updates INTERNATIONAL PARALYMPIC COMMITTEE 3 INTRODUCTION These Qualification Regulations (Regulations) describe in detail how athletes and teams can qualify for the Tokyo 2020 Paralympic Games in each of the twenty- two (22) sports on the Tokyo 2020 Paralympic Games Programme (Games Programme). It provides to the National Paralympic Committees (NPCs), to National Federations (NFs), to sports administrators, coaches and to the athletes themselves the conditions that allow participation in the signature event of the Paralympic Movement. These Regulations present: • an overview of the Games Programme; • the general IPC regulations on eligibility; • the specific qualification criteria for each sport (in alphabetical order); and • a glossary of the terminology used throughout the Regulations. STRUCTURE OF SPORT-SPECIFIC QUALIFICATION
    [Show full text]
  • Freizeitangebote UNTERWEGS
    KLASSE(N) Freizeitangebote UNTERWEGS... ANGEBOTE Ausflugstipps in der FÜR SCHULEN & KINDER Samtgemeinde Uelsen … zu Fuß Ein Hirte hütet seine Schafe – Hütevorführung Wanderkarten mit verschiedenen Wanderwegen rund mit ausgebildeten Hütehunden um Uelsen und Kartenmaterial der Grafschafter Wir sind für Sie da! Spurensuche erhalten Sie bei uns im Alten Rathaus. Veranstalter: Schäferei Zwafink Besonders zu empfehlen ist der Geschichtspfad UELSEN TOURISTIK Dauer: ca. 1 Stunde Uelser Quellen. Am Markt 7, 49843 Uelsen Preis: auf Anfrage T: 05942 20929 … mit dem Rad Infos & Buchungen: Uelsen Touristik [email protected] Die Samtgemeinde Uelsen samt seiner grünen Um- www.uelsen-touristik.de gebung lässt sich bestens mit dem Fahrrad erkun- den. Gerne informieren wir Sie zu verschiedenen Kinderrallye zum Geschichtspark Uelser Radtouren und Radwanderkarten. Quellen – Ausgearbeitete Kinderrallye, mit ÖFFNUNGSZEITEN: … mit dem Auto Fragen zu verschiedenen Stationen, kostenlos im MÄRZ – OKTOBER In der Samtgemeinde Uelsen und den umliegenden Büro der Uelsen Touristik erhältlich. Mo., Di., Mi. u. Fr. 09.30 – 12.30 Uhr; Orten gibt es tolle Ausflugsziele. Bei uns können Sie 14.00 – 17.00 Uhr passendes Kartenmaterial für Uelsen und Umgebung Dauer: ca. 2 ½ Stunden Do: 09.30 – 12.30 Uhr; erhalten. Preis: kostenlos 14.00 – 18.00 Uhr ... mit der Kutsche Infos: Uelsen Touristik Sa: 09.30 – 12.30 Uhr Oder Sie nehmen Platz in einer Kutsche und ge- nießen die Landschaft und Natur einmal abseits von NOVEMBER – FEBRUAR Stress und Geschwindigkeit. Verschiedene Programmangebote der Mo., Mi. u. Fr. 10.00 – 12.30 Uhr; Jugendherberge Uelsen 14.00 – 17.00 Uhr Veranstalter: Waldjugendherberge/ Di: 14.00 – 17.00 Uhr Lucky Guides Do: 10.00 – 12.30 Uhr Unser Tipp: Entsprechendes Informations- Infos & Buchungen: Waldjugendherberge, und Kartenmaterial finden Sie auch online Tel.
    [Show full text]
  • Effect of Hemoperfusion Using Polymyxin B-Immobilized Fiber on IL-6, HMGB-1, and IFN Gamma in a Neonatal Sepsis Model
    0031-3998/05/5802-0309 PEDIATRIC RESEARCH Vol. 58, No. 2, 2005 Copyright © 2005 International Pediatric Research Foundation, Inc. Printed in U.S.A. Effect of Hemoperfusion Using Polymyxin B-Immobilized Fiber on IL-6, HMGB-1, and IFN Gamma in a Neonatal Sepsis Model MOHAMED HAMED HUSSEIN, TAKENORI KATO, TAKAHIRO SUGIURA, GHADA A. DAOUD, SATOSHI SUZUKI, SUMIO FUKUDA, HISANORI SOBAJIMA, INEKO KATO, AND HAJIME TOGARI Department of Pediatrics, Neonatology and Congenital Disorders [M.H.H., T.K., T.S., G.A.D., S.F., H.S., I.K., H.T.], Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan, Department of Pediatrics [S.S.], Nagoya City Johoku Hospital, Nagoya, Japan, Neonatal Intensive Care Unit [M.H.H.], Pediatric Hospital, Cairo University, Cairo, Egypt, Maternal and Child Health Department [M.H.H., G.A.D.], VACSERA, Giza, Egypt ABSTRACT To evaluate effects of polymyxin B direct hemoperfusion at 6 h. IFN-␥ was only detected in the control group at 9 h. (PMX-DHP) on a neonatal sepsis cecal ligation and perforation Survival times in the PMX-DHP group were longer than in the (CLP) model, in 24 anesthetized and mechanically ventilated control. Thus, PMX-DHP improved septic shock in a neonatal 3-d-old piglets, 16 were assigned to CLP and an arteriovenous septic model. (Pediatr Res 58: 309–314, 2005) extracorporeal circuit from 3 h until 6 h post-CLP, with a PMX-column in PMX-DHP–treated group (8 piglets) and 8 as sham. Plasma lipopolysaccharide (LPS) was measured at before Abbreviations CLP and at 3 and 9 h.
    [Show full text]
  • CONTINUED NEW CATEGORY ACCELERATION Trading Update - Ahead of Closed Period Commencing 28 June 2021
    8 June 2021 BRITISH AMERICAN TOBACCO p.l.c. 2021 First Half Pre-Close Trading Update CONTINUED NEW CATEGORY ACCELERATION Trading update - ahead of closed period commencing 28 June 2021 Jack Bowles, Chief Executive: ‘We are accelerating our transformation to build A Better Tomorrow. We are creating brands of the future and sustainable value for all our stakeholders. We added +1.4m non-combustible product consumers1 in Q1, to reach a total of 14.9m. We are investing and building strong, fast growing international brands in each segment, rapidly accelerating our reach and consumer acquisition, thanks to our digitalisation and our multi-category consumer-centric approach, supported by the right resources and products, and our agile organisation. Our portfolio of non-combustible products is tailored to meet the needs of adult consumers. We are growing New Categories at pace, encouraging more smokers to switch to scientifically substantiated reduced risk alternatives2. We continue to expect 2021 to be a pivotal year for the business, with accelerating New Category revenue growth, a clear pathway to New Category profitability by 2025, and leverage reducing to c.3x by year end. ESG is deeply embedded in our organisation, and we have set ourselves stretching targets: £5bn New Category revenue by 2025; 50 million consumers of non-combustible products and carbon neutrality across our own operations by 20303, which I am confident in delivering. In summary, we are accelerating our transformation with increased investment capitalising on our growing momentum in the New Categories, and a record quarter for consumer acquisition. This, together with our strong business performance, is reflected in our upgraded Group revenue growth guidance of above 5% for 2021.
    [Show full text]
  • Rev Bras Cineantropomhum
    Rev Bras Cineantropom Hum original article DOI: http://dx.doi.org/10.5007/1980-0037.2017v19n2p196 Sport classification for athletes with visual impairment and its relation with swimming performance Classificação esportiva para atletas com deficiência visual e sua relação com o desempenho na natação Elaine Cappellazzo Souto1,2 Leonardo dos Santos Oliveira1 Claudemir da Silva Santos2 Márcia Greguol1 Abstract – The medical classification (MC) adopted for swimmers with vision visual impairment (VI) does not clearly elucidate the influence of vision loss on performance. In a documentary research, the final time in the 50-, 100- and 400-m freestyle events and MC (S11, S12 and S13) of national (n = 40) and international (n = 72) elite swimmers was analyzed. The analysis was performed using the Kruskal-Wallis test and Spearman’s correlation with 95% confidence (P < 0.05) and Cohen’s d was calculated. There was a large effect of MC on the final time in the 50-m (P = 0.034, d = 1.55) for national ath- letes and in the 50-m (P = 0.001, d = 2.64), 100-m (P = 0.001, d = 3.01) and 400-m (P = 0.001, d = 2.88) for international athletes. S12 and S13 classes were faster compared to S11 class for all international events, but only in the 50-m for the national event (P < 0.05). It was found a strong negative relationship between the final time and MC for international athletes (Spearman’s Rho ≥ 0.78). There was a significant influence of MC on the performance of swimmers in freestyle races, especially in international swimmers.
    [Show full text]
  • Conditions-BPSIM Inc. WPS World Series 2021
    BRITISH PARA-SWIMMING INTERNATIONAL MEET (50M) Incorporating the 2021 World Para Swimming World Series 8th to 11th April 2021 CONDITIONS MEET CONDITIONS - BRITISH PARA-SWIMMING INTERNATIONAL MEET (50m). 1. General Conditions a. The British Para Swimming Management Team reserves full powers over the British Para- Swimming International Meet (50m). The Meet Director (or nominated substitute) will be the Promoters representative at the event. b. The Competition shall be held under World Para Swimming (WPS) Rules and Regulations (excepting Protest fees) together with any changes and or additional conditions (printed in the Meet Information). Where WPS Rules do not provide (e.g. Health & Safety Regulations or Child Protection Guidelines) the requirements of Swim England shall apply to events held in England. c. This Meet is a WPS Approved Competition. d. WPS International Classifications will be offered. 2. Protests a. WPS Rule 10.12 governs the management of Technical Protests. Whilst for this event the WPS procedure contained within will be followed, the fees referred to in rules 10.12.2 d and 10.12.6.2 shall in both cases by replaced by the protest fee and appeal fee each being £25. 3. Eligibility a. S1-S10 - All competitors must have WPS Classification, which is held on the WPS Classification Database at the time of entry, except for those on the list for classification immediately preceding the competition. b. S11-S13 - All competitors must have a WPS Classification, which is held on the WPS Classification Database at the time of entry. c. S14 - All competitors must have an authorised INAS-FID or WPS Classification, which is held on the WPS Classification Database at the time of entry.
    [Show full text]
  • BRITISH AMERICAN TOBACCO Science & Technology
    BRITISH AMERICAN TOBACCO Science & Technology 2015 report Foreword 1 Dr David O’Reilly, Group Scientific and R&D Director RESEARCH PRIORITIES Stewardship and next generation products 2 Dr Christopher Proctor PLANT BIOTECHNOLOGY From seed to smoke 4 Dr Kieron Edwards GOOD RESEARCH PRACTICE Good research practice — securing innovation 7 John McBrearty ANALYTICAL METHOD DEVELOPMENT Chemical characterisation of next generation Science & products 8 Dr Christopher Wright Technology POPULATION STUDIES Assessing the impact of new products 11 2015 Oscar Camacho STEWARDSHIP Leading the way in product risk assessment 14 About this Report This is a British American Tobacco p.l.c. report describing Dr Audrey Richter some of the activity of British American Tobacco Group Research & Development in the UK. References to ‘British TOBACCO HEATING PRODUCTS American Tobacco’, ‘we’, ‘us’ and ‘our’ when denoting Eliminating combustion to potentially opinion or activity refer to British American Tobacco Group Research & Development. reduce risk 16 Whilst reasonable steps have been taken to ensure that Dr Chuan Liu the information contained within this publication is correct, the authors, British American Tobacco, its agents, ELECTRONIC CIGARETTES contractors and sub-contractors give no warranty and make no representation as to its accuracy and aaccept no liability Rapid evolution presents new challenges 20 for any errors or omissions. Dr Kevin McAdam Any trademarks, service marks or logos used in this publication, and copyright in it, are the property of British
    [Show full text]